Control of ixodid ticks and prevention of tick-borne diseases in the United States: The prospect of a new Lyme disease vaccine and the continuing problem with tick …

L Eisen - Ticks and tick-borne diseases, 2021 - Elsevier
Abstract In the United States, exposure to human-biting ixodid ticks can occur while
spending time on residential properties or in neighborhood green spaces as well as during …

Pathogenicity and virulence of Borrelia burgdorferi

M Strnad, N Rudenko, ROM Rego - Virulence, 2023 - Taylor & Francis
Infection with Borrelia burgdorferi often triggers pathophysiologic perturbations that are
further augmented by the inflammatory responses of the host, resulting in the severe clinical …

[HTML][HTML] Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

M Pine, G Arora, TM Hart, E Bettini, BT Gaudette… - Molecular Therapy, 2023 - cell.com
Lyme disease is the most common vector-borne infectious disease in the United States, in
part because a vaccine against it is not currently available for humans. We propose utilizing …

Human B cell epitope map of the Lyme disease vaccine antigen, OspA

HME Haque, M Ejemel, DJ Vance… - ACS Infectious …, 2022 - ACS Publications
The Lyme disease (LD) vaccine formerly approved for use in the United States consisted of
recombinant outer surface protein A (OspA) from Borrelia burgdorferi sensu stricto (ss), the …

A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease

GP Wormser - Diagnostic Microbiology and Infectious Disease, 2022 - Elsevier
ABSTRACT The only United States Food and Drug Administration approved vaccine
preparation to prevent Lyme disease consisted of a single recombinant outer surface protein …

A ticking time bomb hidden in plain sight

S Narasimhan, D Fish, JHF Pedra, U Pal… - Science Translational …, 2023 - science.org
The deer tick transmits nearly half of the known tick-borne pathogens in the United States,
and its expanding geographic range increases the risk of human infection. To decrease the …

Structure of a transmission blocking antibody in complex with Outer surface protein A from the Lyme disease spirochete, Borreliella burgdorferi

MJ Rudolph, SA Davis, HME Haque… - Proteins: Structure …, 2023 - Wiley Online Library
44 is a human monoclonal antibody capable of passively protecting mice against tick‐
mediated infection with Borreliella burgdorferi, the bacterial genospecies responsible for …

Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights

WH Chen, U Strych, ME Bottazzi… - Expert review of vaccines, 2022 - Taylor & Francis
ABSTRACT Introduction Transmitted by ticks, Lyme disease is the most common vector-
borne disease in the Northern hemisphere. Despite the geographical expansion of human …

[HTML][HTML] Tick-Tattoo: DNA Vaccination Against B. burgdorferi or Ixodes scapularis Tick Proteins

MJ Klouwens, JJA Trentelman, A Wagemakers… - Frontiers in …, 2021 - frontiersin.org
Introduction Borrelia burgdorferi sensu lato (sl) is the causative agent of Lyme borreliosis.
Currently there is no human vaccine against Lyme borreliosis, and most research focuses …

[HTML][HTML] Repeated Tick Infestations Impair Borrelia burgdorferi Transmission in a Non-Human Primate Model of Tick Feeding

S Narasimhan, CJ Booth, MT Philipp, E Fikrig… - Pathogens, 2023 - mdpi.com
The blacklegged tick, Ixodes scapularis, is the predominant vector of Borrelia burgdorferi,
the agent of Lyme disease in the USA. Natural hosts of I. scapularis such as Peromyscus …